Accendra Health (ACH) Price to Sales (2009 - 2026)

Accendra Health (ACH) has reported Price to Sales for 18 consecutive years, with 0.43 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 58.37% year-over-year to 0.43 in Q2 2026; TTM through Jun 2026 was 0.1, a 61.28% decrease from a year earlier, with the FY2025 full-year figure at 0.08, down 79.43% from the prior year.
• Price to Sales was 0.43 for Q2 2026 at Accendra Health, up from 0.28 in the prior quarter.
• Over five years, Price to Sales peaked at 1.76 in Q3 2024 and troughed at 0.29 in Q4 2023.
• A 5-year average of 0.78 and a median of 0.66 in 2022 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales sank 149.28% in 2023 and jumped 604.43% in 2024, its largest moves.
• Over 5 years, Price to Sales stood at 0.58 in 2022, then sank by 149.28% to 0.29 in 2023, then jumped by 604.43% to 1.45 in 2024, then tumbled by 79.22% to 0.3 in 2025, then jumped by 42.17% to 0.43 in 2026.
• The last three Price to Sales figures came in at 0.43 (Q2 2026), 0.28 (Q1 2026), and 0.3 (Q4 2025), per Business Quant data.